Altering Sedation Paradigms to Improve Brain Injury and Survival in Severe Sepsis
Phase of Trial: Phase III
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Dexmedetomidine (Primary) ; Propofol (Primary)
- Indications Delirium
- Focus Biomarker; Therapeutic Use
- Acronyms MENDS II
- 07 Jun 2017 Biomarkers information updated
- 01 Jun 2017 Planned number of patients changed from 530 to 420.
- 14 Nov 2016 Planned End Date changed from 1 Jun 2017 to 1 Dec 2018.